Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

ABVC Biopharma Inc

ABVC ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$0.90

▼ -6.51%

Market Cap $23.99M · Vol 9.09K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$23.99M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

38.87

Momentum

Beta

0.58

vs Market

52W High

$3.39

73.54% below

52W Low

$0.87

3.12% above

Volume

9.09K

Avg 26.84K

P/B

4.80

Price-to-book

ROE

N/A

Return on equity

Free Float

81.89%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, ABVC Biopharma Inc (ABVC) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ABVC pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-12.07%

-33.07%

-16.95%

-45.97%

YTD

-57.89%

-70.50%

-53.04%

-96.13%

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-8,376,960.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-58.41% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	4.80
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	26.65M

Technical Indicators

50-Day SMA	$1.29
200-Day SMA	$1.66
RSI (14)	38.87
Beta	0.58
52-Week High	$3.39
52-Week Low	$0.87

Volume Today	9.09K
Avg Daily Volume (30D)	26.84K
Relative Volume	0.34x
Volatility (10D)	61.68
Volatility (30D)	119.33
Free Float	81.89%

Analyst Consensus

N/A

Current Price $0.90

Mean Target N/A

52W Low$0.87 52W High$3.39

Current

Target

$0.87 $3.39

Current Analyst target

· 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SMCS49

ISINUS00091F3047

CountryUnited States of America

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

ABVC Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of new drugs and medical devices, all of which are derived from plants. Its pipeline includes ABV-1504, ABV-1505, ABV-1601, ABV-1702, ABV-1703, ABV-1501, and ABV-1701. The Company is developing and researching ABV-1504, a botanical reuptake inhibitor that targets norepinephrine. ABV-1505 to treat attention deficit hyperactivity disorder (ADHD). It has developed ABV-1601 for treating depression in cancer patients. ABV-1702 to treat Myelodysplastic syndromes. It has developed an indication for pancreatic cancer from maitake extract, named ABV-1703. ABV-1501 for the treatment of Triple Negative Breast Cancer. ABV-1701 Vitargus for the treatment of Retinal Detachment or Vitreous Hemorrhage. ABV-1519 for the treatment of Non-Small Cell Lung Cancer.